Spiral Therapeutics Inc
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Other
- Headquarters
- South San Francisco, CA
- Street
- 6000 Shoreline Court
- Zip
- 94080
Offering
- Total offering
- $27.1M
- Amount sold
- $27.1M
- First sale
- Sep 30, 2025
- Min investment
- $0
- Securities
- Equity
- Federal exemption
- Rule 506(b)
- Investors so far
- 34
How this filing compares
Ranked #76 of 611 Other filings in April 2026 by offering amount.
Median Other filing in April 2026: $4.3M. This offering is 6.3× the median.
Other California filings this week: Blue Opportunity Fund, LP, CHECKPOINT CAPITAL (OFFSHORE) FUND LP, CHECKPOINT CAPITAL (ONSHORE) FUND LP, CompleteFarmer Technologies, Inc., ExchangeRight Income Fund Operating Partnership, LP
Leadership
HUGO PERIS — Executive Officer (also: Director)
ANTHONY ADAMIS — Director
EUGENE DE JUAN — Executive Officer (also: Director)
GUY JEAN SAVOIR GARCIA — Director
ANGELA MACFARLANE — Director
FREDERIC GUERARD — Director
DIAMANTIS XYLAS — Director
JEAN-FREDERIC PAULSEN — Director
WARREN THALER — Director
Filing details
Spiral Therapeutics Inc filed a Form D with the SEC on April 16, 2026.